English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/95124
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation

AuthorsYanguas-Casás, Natalia; Barreda-Manso, M. Asunción ; Nieto-Sampedro, Manuel ; Romero-Ramírez, Lorenzo
Bile salts
Inducible nitric oxide synthase
Monocyte chemotactic protein-1
Protein kinase RNA-activated
Vascular cell adhesion molecule 1
Issue Date19-Mar-2014
PublisherBioMed Central
CitationJournal of Neuroinflammation 11(1): 50 (2014)
Abstract[Background] Bile acids are steroid acids found predominantly in the bile of mammals. The bile acid conjugate tauroursodeoxycholic acid (TUDCA) is a neuroprotective agent in different animal models of stroke and neurological diseases. However, the anti-inflammatory properties of TUDCA in the central nervous system (CNS) remain unknown. [Methods] The acute neuroinflammation model of intracerebroventricular (icv) injection with bacterial lipopolysaccharide (LPS) in C57BL/6 adult mice was used herein. Immunoreactivity against Iba-1, GFAP, and VCAM-1 was measured in coronal sections in the mice hippocampus. Primary cultures of microglial cells and astrocytes were obtained from neonatal Wistar rats. Glial cells were treated with proinflammatory stimuli to determine the effect of TUDCA on nitrite production and activation of inducible enzyme nitric oxide synthase (iNOS) and NFκB luciferase reporters. We studied the effect of TUDCA on transcriptional induction of iNOS and monocyte chemotactic protein-1 (MCP-1) mRNA as well as induction of protein expression and phosphorylation of different proteins from the NFκB pathway. [Results] TUDCA specifically reduces microglial reactivity in the hippocampus of mice treated by icv injection of LPS. TUDCA treatment reduced the production of nitrites by microglial cells and astrocytes induced by proinflammatory stimuli that led to transcriptional and translational diminution of the iNOS. This effect might be due to inhibition of the NFκB pathway, activated by proinflammatory stimuli. TUDCA decreased in vitro microglial migration induced by both IFN-γ and astrocytes treated with LPS plus IFN-γ. TUDCA inhibition of MCP-1 expression induced by proinflammatory stimuli could be in part responsible for this effect. VCAM-1 inmunoreactivity in the hippocampus of animals treated by icv LPS was reduced by TUDCA treatment, compared to animals treated with LPS alone. [Conclusions] We show a triple anti-inflammatory effect of TUDCA on glial cells: i) reduced glial cell activation, ii) reduced microglial cell migratory capacity, and iii) reduced expression of chemoattractants (e.g., MCP-1) and vascular adhesion proteins (e.g., VCAM-1) required for microglial migration and blood monocyte invasion to the CNS inflammation site. Our results present a novel TUDCA anti-inflammatory mechanism, with therapeutic implications for inflammatory CNS diseases.
Publisher version (URL)http://dx.doi.org/10.1186/1742-2094-11-50
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
1742-2094-11-50.xml86,34 kBXMLView/Open
1742-2094-11-50-S3.PDF392,92 kBAdobe PDFThumbnail
1742-2094-11-50-S1.PDF13,62 MBAdobe PDFThumbnail
1742-2094-11-50-S2.PDF329,11 kBAdobe PDFThumbnail
1742-2094-11-50.pdf2,77 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.